✦ LIBER ✦

VEGF pathway-targeted therapy for advanced renal cell carcinoma: A meta-analysis of randomized controlled trials

✍ Scribed by Fei Liu; Xianguo Chen; Ejun Peng; Wei Guan; Youyuan Li; Zhiquan Hu; Zhangqun Ye; Qianyuan Zhuang

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Octreotide for advanced hepatocellular c

✍ Tian-Kang Guo; Xiang-Yong Hao; Bin Ma; Ke-Hu Yang; Yi-Ping Li; Hong-Ling Li; Yua 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 326 KB

Cetuximab-based therapy versus non-cetux

✍ Lidan Liu; Yunfei Cao; Aihua Tan; Cun Liao; Feng Gao 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 633 KB

Chronomodulated chemotherapy versus conv

✍ Cun Liao; Jing Li; Qiong Bin; Yunfei Cao; Feng Gao 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 162 KB

The addition of tocilizumab to DMARD the

✍ Mao Mao An; Zui Zou; Hui Shen; Jun Dong Zhang; Yong Bing Cao; Yuan Ying Jiang 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 387 KB

A meta-analysis of randomized controlled

✍ Takahiro Uchida; Ameet Bakhai; Alexandra Almonacid; Taro Shibata; Barbra Cox; Ri 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 193 KB

Cetuximab-based Therapy is Effective in

✍ Ezzeldin M. Ibrahim; Khaled M. Abouelkhair; Osama A. Al-Masri; Najeeb C. Chaudry 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 295 KB